Apollomics, Inc.

Crescent Biopharma may be behind in the race to introduce a PD-1xVEGF bispecific antibody, but the firm has a clearer path now that it is going public through a reverse merger with GlycoMimetics and

MEI Pharma, Inc. said on 22 July that its board of directors unanimously agreed to hire a financial consultant that can help the company assess strategic alternatives to maximize the value of its ass

GlycoMimetics, Inc. is hoping that mining the data from its failed Phase III pivotal trial of uproleselan in acute myeloid leukemia (AML) can potentially yield some evidence of benefit in subgroup po

Chinese biotech Avistone Pharmaceuticals has won full approval in China for vebreltinib (also known as bozitinib) for a rare subtype of glioblastoma, making the molecule the world’s first c-Met inhi